Science1 publisherNot yet confirmed elsewhere2 min readPublished
IEEE poll of 166 experts expects gene therapy to be used frequently by 2028
IEEE's 2030 Technology Megatrends Report, built from 166 experts in 38 countries, forecasts frequent use of gene therapy by 2028. The dates are graded expert opinion, good for seeing where specialists expect medicine and energy to go and a weaker guide to timing than clinical trials.
The Scientist · Science desk

What happened
- The report's 30 technologies fall under five megatrends: AI, energy, health, space and physical AI.
- Personalized medicine scored highest of the 30 for its potential to improve human life, at 4.93 out of 5.
- Within five years, the report expects earlier disease diagnosis to move out of the lab and into day-to-day medical practice.
- The experts expect energy storage in developed countries to double within two to three years.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
- constraint Because AI sits under many of the 30 technologies, a shortfall in computing or power would delay several forecasts together, the AI-driven health timelines among them.
- cost If more efficient chips lead organizations to run more chips, as the Jevons argument holds, cheaper computation adds to grid load, and the cost falls on power systems that take months to respond.
- decision Investors and hospital planners treating 2028 as a gene therapy date need the likelihood and horizon grades too, because impact is only one of the five criteria the experts scored.
The method is a graded poll. The experts scored each of the 30 technologies on five criteria: likelihood of success, impact to humanity, maturity, market adoption and horizon to adoption [8]. The panel came from industry, academia and government on six continents [7]. Spread over 38 countries, 166 people works out to about four per country [18].
Personalized medicine's 4.93 is 0.07 below the top of the scale [19]. An average that close to the ceiling leaves little room for dissent about impact. The thing this doesn't tell you is whether the same experts expect it soon. Spectrum's summary of the report gives the impact score but not personalized medicine's grades for likelihood, maturity or horizon, and it does not say how many of the 166 rated each technology.
The gene therapy forecast appears in two wordings. The headline version says genetic engineering and gene therapy will be used frequently to treat a variety of diseases by 2028, thanks to advances in AI [1]. Later in the same account, the experts predict that within two years they will be used in therapeutic areas [5]. In my view the second wording is a much easier test to pass. The report also expects researchers to be able to make simple synthetic proteins, engineered from scratch, to do one job in the body, such as targeting a tumor or supplying a missing enzyme [12].
AI underpins many of the 30 technologies [6]. Dejan Milojicic chairs the IEEE Future Directions Committee's Industry Advisory Board, the group responsible for the report, and is a vice president at HPE Labs [17]. "Artificial intelligence is no longer operating in a vacuum; it is now deeply connected to our energy, infrastructure, and physical systems," he said [9]. The report lists the lack of computing infrastructure and energy sources as constraints on scaling AI [2]. It names trust, security, explainability and policymaking as the conditions that will decide which AI-supported technologies scale [3]. Mary Ellen Randall, IEEE's 2026 president and CEO, said in a news release that "trust, safety, and human connection must guide every major breakthrough in the decade ahead" [4].
IEEE's news release estimates that data centers, networks and computing hardware already use about 10 percent of the world's electricity [15]. "Data centers can ramp up within milliseconds, yet it takes months for the power and energy sector to ramp up," Milojicic said [16]. The experts also cite the Jevons paradox, the idea that efficiency gains tend to raise overall consumption. As AI chips become more efficient, they argue, organizations will run more hardware to build ever-larger frontier models [14].
What to watch
- Release of the full report's likelihood, maturity and horizon grades for personalized medicine and gene therapy, along with how many of the 166 experts rated each technology.
- Whether energy storage in developed countries doubles within the two-to-three-year window the experts gave, the earliest forecast in the report that utility data can check.
- Whether gene therapy use by 2028 meets the 'frequently' wording or only the looser 'used in therapeutic areas' version of the same forecast.